IL179717A0 - Amorphous clopidogrel hydrochloride and its antithrombotic use - Google Patents
Amorphous clopidogrel hydrochloride and its antithrombotic useInfo
- Publication number
- IL179717A0 IL179717A0 IL179717A IL17971706A IL179717A0 IL 179717 A0 IL179717 A0 IL 179717A0 IL 179717 A IL179717 A IL 179717A IL 17971706 A IL17971706 A IL 17971706A IL 179717 A0 IL179717 A0 IL 179717A0
- Authority
- IL
- Israel
- Prior art keywords
- clopidogrel hydrochloride
- amorphous clopidogrel
- antithrombotic
- antithrombotic use
- amorphous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0412172A GB0412172D0 (en) | 2004-06-01 | 2004-06-01 | Amorphous form of clopidogrel hydrochloride and its use as an antithrombotic compound |
GB0418395A GB0418395D0 (en) | 2004-08-18 | 2004-08-18 | Amorphous form of clopidogrel hydrochloride and its use as an antithrombotic compound |
PCT/US2005/019326 WO2005117866A1 (en) | 2004-06-01 | 2005-06-01 | Amorphous clopidogrel hydrochloride and its antithrombotic use |
Publications (1)
Publication Number | Publication Date |
---|---|
IL179717A0 true IL179717A0 (en) | 2007-05-15 |
Family
ID=34971760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL179717A IL179717A0 (en) | 2004-06-01 | 2006-11-30 | Amorphous clopidogrel hydrochloride and its antithrombotic use |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1750701A1 (en) |
IL (1) | IL179717A0 (en) |
WO (1) | WO2005117866A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006074066A1 (en) * | 2004-12-30 | 2006-07-13 | Nektar Therapeutics | Non-crystalline formulation comprising clopidogrel |
WO2007029096A2 (en) * | 2005-09-05 | 2007-03-15 | Ranbaxy Laboratories Limited | Novel polymorphic forms of clopidogrel hydrochloride |
WO2007128476A1 (en) * | 2006-05-04 | 2007-11-15 | Sandoz Ag | Pharmaceutical compositions containing clopidogrel hydrochloride |
EP1970054A3 (en) | 2007-03-14 | 2009-06-03 | Ranbaxy Laboratories Limited | Clopidogrel tablets |
EP2107061A1 (en) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2530247B1 (en) * | 1982-07-13 | 1986-05-16 | Sanofi Sa | NOVEL THIENO (3, 2-C) PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC APPLICATION |
FR2623810B2 (en) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
WO2002018357A1 (en) * | 2000-08-29 | 2002-03-07 | Rpg Life Sciences Limited | A ONE-POT PROCESS FOR THE PREPARATION OF PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS OF 4, 5, 6, 7 - TETRAHYDROTHIENO (3,2-c) PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY |
ES2316650T3 (en) * | 2001-12-18 | 2009-04-16 | Teva Pharmaceutical Industries Ltd. | CLOPIDOGREL HYDROGENOSULPHATE POLYMORPHES. |
HUP0200438A3 (en) * | 2002-02-06 | 2003-10-28 | Egis Gyogyszergyar Nyilvanosan | Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them |
GB2393181A (en) * | 2002-09-19 | 2004-03-24 | Cipla Ltd | Amorphous clopidogrel |
-
2005
- 2005-06-01 WO PCT/US2005/019326 patent/WO2005117866A1/en not_active Application Discontinuation
- 2005-06-01 EP EP05756511A patent/EP1750701A1/en not_active Withdrawn
-
2006
- 2006-11-30 IL IL179717A patent/IL179717A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005117866A1 (en) | 2005-12-15 |
EP1750701A1 (en) | 2007-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL182498A0 (en) | Therapeutic furopyrimidines and thienopyrimidines | |
EP1826209A4 (en) | Nitromethylene derivatives and their use | |
EP1731506A4 (en) | 5-hydroxyindole-3-carboxylates derivatives and their use | |
EP1776148A4 (en) | Ophthalmic devices and related methods and compositions | |
IL181670A0 (en) | Substituted phenylaminothiazoles and use thereof | |
HK1101911A1 (en) | Tetrahydrocarbozoles and derivatives | |
GB0620329D0 (en) | Pentathienyl-fluorene copolymer | |
IL181867A0 (en) | Crystalline clopidogrel hydrobromide and processes for preparation thereof | |
IL178888A0 (en) | Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives | |
TWI366696B (en) | Contact lenses and methods for their design | |
EP1818345A4 (en) | Fluorine-containing copolymer | |
IL179717A0 (en) | Amorphous clopidogrel hydrochloride and its antithrombotic use | |
HK1089139A1 (en) | Engaging device and transfer instrument | |
IL178216A0 (en) | Clopidogrel salt and polymorphic forms thereof | |
HK1097495A1 (en) | Can body and can | |
EP1810976A4 (en) | Benzonaphthaceneglycoside derivative and use thereof | |
IL183234A0 (en) | Amorphous tacrolimus and preparation thereof | |
GB0508011D0 (en) | Intra-vaginal device | |
IL161927A0 (en) | Prayer reminder device | |
GB0418395D0 (en) | Amorphous form of clopidogrel hydrochloride and its use as an antithrombotic compound | |
GB0412172D0 (en) | Amorphous form of clopidogrel hydrochloride and its use as an antithrombotic compound | |
GB0427723D0 (en) | Compounds and their use | |
IL165458A0 (en) | And | |
GB0410833D0 (en) | Compounds and their use | |
GB0407628D0 (en) | Compounds and their use |